Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 28 lut 2022 · IUD expulsions were analyzed in the full study cohort by postpartum timing interval at insertion and in the subcohort of women with breastfeeding status. We estimated incidence rates, cumulative incidence, and crude and adjusted hazard ratios (HRs) and their 95% CIs for risk of IUD expulsion.

  2. 29 kwi 2022 · The 52-mg levonorgestrel-releasing intrauterine system maintains an excellent safety profile and contraceptive efficacy through 8 years. For years 6 to 8, the 3-year Pearl Index (95% confidence interval) was 0.28 (0.03–1.00) with a 3-year cumulative failure rate of 0.68% (0.17–2.71).

  3. 15 cze 2024 · Three hundred twenty lactating women were randomized to either an IUD containing levonorgestrel (Mirena; n = 163) or the copper-containing IUD Cu T380A group (n = 157). Follow-up of infants for 1 year found no differences in growth and development or in duration of breastfeeding.

  4. 4 cze 2022 · Among individuals 52 weeks or less post partum, we found an increased risk of uterine perforation with breastfeeding at IUD insertion, but this added risk was smaller than previously reported and was most pronounced in the later post partum insertions.

  5. we compared uterine perforation risk among those who were and were not breastfeeding at the time of IUD insertion. We present new data on partial versus complete perforations, more granular data on post-partum interval risks, and data on subpopulations previously not well described, including non-post-partum and immediate post-partum insertions.

  6. The risk of uterine perforation is increased in women who have recently given birth, and in women who are breastfeeding at the time of insertion. In a large US retrospective, postmarketing safety study of IUDs, the risk of uterine perforation was highest when insertion occurred within ≤6 weeks postpartum, and also higher with breastfeeding at ...

  7. INDICATIONS FOR MIRENA. Mirena® is indicated for prevention of pregnancy for up to 8 years; replace after the end of the eighth year. Mirena is indicated for the treatment of heavy menstrual bleeding for up to 5 years in women who choose to use intrauterine contraception as their method of contraception; replace after the end of the fifth year ...

  1. Ludzie szukają również